San Francisco Healthcare System
San Francisco, California, 94121, United States
Location status: Recruiting
NCT Number: NCT06080646
Deficits in motivation and pleasure are common in depression, and thought to be caused by alterations in the ways in which the brain anticipates, evaluates, and adaptively uses reward-related information. However, reward processing is a complex, multi-circuit phenomenon, and the precise neural mechanisms that contribute to the absence or reduction of pleasure and motivation are not well understood. Variation in the clinical presentation of depression has long been a rule rather than an exception, including individual variation in symptoms, severity, and treatment response. This heterogeneity complicates understanding of depression and thwarts progress toward disease classification and treatment planning. Discovery of depression-specific biomarkers that account for neurobiological variation that presumably underlies distinct clinical manifestations is critical to this larger effort.
Interested in participating?
Request Info18 year–70 year
All sexes
Observational
San Francisco, California, 94121, United States
Location status: Recruiting
This study combines clinically motivated questions with in-depth study of neurobiological mechanisms to evaluate how reward system neurobiology contributes to expression of reward-related deficits, such as decreased pleasure and motivation in major depressive disorder (MDD). Conceptually, the investigator will use a multi-measure approach, by studying basic brain responses to reward anticipation as well as higher-order aspects of reward processing necessary for decision-making.
Methodologically, the investigator will combine fMRI, EEG, and behavioral assessment, to more fully characterize reward-related brain functions and their clinical correlates. In addition to evaluating reward effects between MDD and healthy controls (HC), the investigator will also focus on understanding the relationship between reward processing and clinical features of high relevance to depression, with an emphasis on suicidality.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
n/a there is no intervention in this observational study
Other names: cross-sectional MRI and EEG assessments
Time frame: 1 month (EEG measure of reward anticipation)
Stimulus preceding negativity (EEG measure of reward anticipation) of reward-related brain activation patterns and EEG responses on participants
Time frame: 1 month (EEG measure of reward feedback)
Reward positivity (EEG measure of reward feedback) of reward-related brain activation patterns and EEG responses on participants
Time frame: 1 month (EEG measure of effective salience)
Late positive potential (EEG measure of affective salience) of reward-related brain activation patterns and EEG responses on participants
Time frame: 1 month (fMRI data)
fMRI response to win vs. loss reward feedback of reward-related brain activation patterns and EEG responses on participants
Contact information is provided by the study sponsor or research team.
Jason Hemmerle, MBA
CONTACT
415 221 4810 ext. 24711
Kaitlyn Dal Bon, BA
CONTACT
415 221 4810 ext. 23946
San Francisco Veterans Affairs Medical Center
Fed
Reward Processing and Depressive Subtypes: Identifying Neural Biotypes Related to Suicide Risk, Resilience, and Treatment Response
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07512284
Behavior, Behavioral Symptoms
San Diego, California, United States
View Trial DetailsNCT05925322
Behavior, Behavioral Symptoms
New York, United States
View Trial DetailsNCT04572321
Anxiety Disorders, Behavior
Dallas, Texas, United States
View Trial DetailsNCT05547711
Behavior, Behavioral Symptoms
Munich, Bavaria, Germany
View Trial Details